Advertisement
Screener

ANGIOGENEX, INC. Patents: Applications Pending

ANGIOGENEX, INC. Patent Applications Pending

2 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2014-12-14: Application PCTUS2014070221; Invention COMPOSITIONS AND METHODS FOR TREATING, PREVENTING AND DIAGNOSING CANCER AND OTHER PROLIFERATIVE DISORDERS; Applicant ANGIOGENEX, INC.; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
  • 2007-01-26: Application PCTUS2007002137; Invention RABBIT MONOCLONAL ANTIBODIES AGAINST MOUSE/; Applicant ANGIOGENEX, INC.; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2014-12-14PCTUS2014070221COMPOSITIONS AND METHODS FOR TREATING, PREVENTING AND DIAGNOSING CANCER AND OTHER PROLIFERATIVE DISORDERSANGIOGENEX, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
WILLIAM A. GARLAND
GLEN STOLLER
JAIDEEP CHAUDHARY
United States
United States
United States
THOMAS, SHANE M
2007-01-26PCTUS2007002137RABBIT MONOCLONAL ANTIBODIES AGAINST MOUSE/HUMAN ID3 PROTEINSANGIOGENEX, INC.
BIOCHECK, INC.
RO PROCESSING COMPLETED-PLACED IN STORAGE
WILLIAM A. GARLAND
JUNG-SHOU CHEN
United States
United States
FOLEY, SHANON A